MondayJun 06, 2022 3:11 pm

TinyGemsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Immune Monitoring Platform ‘Is the Right Technology at the Right Time’

Aditxt (NASDAQ: ADTX) recently entered into a multi-year partnership with Guthy-Renker LLC- affiliated GRS. The partnership focuses on building awareness and visibility among consumers and health care providers for the proprietary AditxtScore(TM) Immune Monitoring Platform. “AditxtScore is the right technology at the right time. Our first application, AditxtScore for COVID-19, delivers timely reports on vulnerability and immune status to SARS-CoV-2 and its known variants, giving consumers and their physicians the data they need to make informed health decisions for themselves and their families,” Aditxt CEO and Co-Founder Amro Albanna was quoted in a recent article. Albanna added that the company’s…

Continue Reading

FridayMay 27, 2022 3:14 pm

TinyGemsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Eyeing Expansion, Scaling

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, has historically focused on business-to-business (“B2B”) operations, providing gaming companies with the tools they need to improve profits and reduce churn, industry nomenclature for losing players. “Golden Matrix IP includes its flagship GM-X System and its recently released next-gen GM-Ag System that is regarded as the industry benchmark, delivering access to 10,000+ games from more than 25 providers,” a recent article reads. “Most of Golden Matrix’s business comes from the Asia Pacific, but management is looking to expand closer to home. In March, the…

Continue Reading

MondayMay 23, 2022 1:49 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Among Most Powerful of Chemotherapy Drugs

CNS Pharmaceuticals’ (NASDAQ: CNSP) novel anthracycline Berubicin, which has been developed to treat diseases with unmet need such as the deadly glioblastoma (“GBM”), appears to be the first anthracycline chemotherapy agent to successfully cross the blood-brain barrier in targeting tumors of the central nervous system. “Berubicin was the drug candidate subject of a small-scale phase 1 clinical trial in 2006 that evaluated its safety, which was notable because one of the two dozen evaluated patients emerged cancer-free and has remained so over the subsequent 16 years. Nearly half of the trial’s patients experienced a statistically significant improvement in clinical benefit.…

Continue Reading

MondayMay 23, 2022 1:39 pm

TinyGemsBreaks – Silo Pharma Inc. (SILO) Bringing Hope to Patients Suffering from Alzheimer’s and Potentially Other Ailments

Silo Pharma (OTCQB: SILO) is exploring the efficacy of ketamine in treating patients suffering from both Alzheimer’s and Parkinson’s disease. With more than 80% of Parkinson’s patients and 75% of Alzheimer’s patients experiencing dysphagia, difficulty or complete inability to swallow, last year, SILO entered into a joint venture with Zylö Therapeutics. Under the collaboration, the companies will explore an innovative technology – ZTI’s Z-pod transdermal technology – to develop a ketamine delivery system for those suffering from dysphagia. “In October 2021, Silo entered into a sponsored research agreement with Columbia University incorporating the work of Dr. Christine Ann Denny. According…

Continue Reading

MondayMay 23, 2022 1:11 pm

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Partners to Help Accelerate Regulatory Pathway of CYB003

Cybin (NYSE American: CYBN) (NEO: CYBN) is moving forward with its phase 1/2a clinical trial of its proprietary deuterated psilocybin, CYB003, which, previous research shows, has the potential to effectively treat major depressive disorder (“MDD”) with significant advantages over classic psilocybin. MDD impacts over 264 million people worldwide, 1/3 to 1/2 of whom demonstrate an inadequate response to antidepressant drug treatment. Against this backdrop, Cybin focuses on finding solutions for those whose lives are impacted by MDD and other mental and emotional disorders. “The company recently completed in vivo preclinical studies of CYB003. The company plans to file an investigational…

Continue Reading

MondayMay 23, 2022 12:44 pm

TinyGemsBreaks – Advanced Container Technologies Inc.’s (ACTX) GrowPods Suited to Build More Resilient Food Production Capabilities

Advanced Container Technologies (OTC: ACTX) is ideally situated to help meet the needs of the new U.S. Department of Agriculture’s (“USDA”) Local Food Purchase Assistance Cooperative Agreement Program (“LFPA”), which sets out to build a new and more equitable food system. The LFPA is intended to enable “state, tribal and local entities to purchase food more efficiently from local producers and invest in infrastructure that enables partner organizations to reach underserved communities more effectively,” a recent article reads. “According to Advanced Container Technologies, its GrowPods – modular hydroponic greenhouses – could become a valuable tool in this effort to build…

Continue Reading

MondayMay 23, 2022 12:29 pm

TinyGemsBreaks – Eat Well Investment Group Inc.’s (CSE: EWG) (OTC: EWGFF) Sapientia Taking over Snack Food Market One Product at a Time

Eat Well Investment Group’s (CSE: EWG) (OTC: EWGFF) Sapientia Technology LLC subsidiary, a food technology portfolio enterprise acquired in June 2021, launched its first white-label, better-for-you plant-based twisted curls in December 2021. “This specific product, the Co-op Gold PURE Plant-Based Protein Twists, would be sold in over 300 Federated Co-op stores across Western Canada as well as secure finalist status in the 29th annual Canadian Grand Prix New Product Awards… The product launch was a move by Sapientia to disrupt the multibillion-dollar snack food market by offering taste and nutrition ‘without compromise.’ Winning the finalist status at the recent Canadian…

Continue Reading

FridayApr 22, 2022 9:30 am

TinyGemsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Move to Begin EV Battery Pack Production Featured in Recent Articles

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was featured in recent articles published by and Auto Futures that discussed the company’s plans to begin EV battery pack production out of its high voltage battery R&D facility located in Monrovia, California. Mullen is in the process of retrofitting its facility to accommodate production of the EV battery packs destined for its EV vehicle line-up, which includes the ONE EV Cargo Van, FIVE EV Crossover and DragonFLY EV Sportscar. “Building our own battery packs makes sense as it reduces our reliance on third-party suppliers and lessens our risk…

Continue Reading

MondayMar 07, 2022 10:00 am

TinyGemsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) FIVE EV Crossover Featured in Clean Fleet Report Article

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was featured in a recent article published by the Clean Fleet Report. The piece titled “A Quick Look at What Is on the Electric Horizon,” provides a glimpse of the future of EVs. “With a corporate motto of ‘Imagine What’s Possible,’ the Southern California-based Mullen Technologies planted its flag in 2014 with the goal of helping to lower the impact of fossil fuels on the environment. Their first foray into being part of the solution for better air will be the Mullen FIVE with an estimated 325-mile all-electric driving range.…

Continue Reading

FridayMar 04, 2022 9:30 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Featured in Automotive Web Zine Carscoops

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was featured in a recent article published by Carscoops. The piece, written by Stephen Rivers, discusses Mullen Automotive’s progress on a solid-state battery. “As the transition to electrified vehicles continues to move forward, one goal is solid-state battery technology. Now, Mullen Automotive, another EV startup aiming to bring luxury electric vehicles to the market, says that they’ve made serious progress,” Rivers writes. “The first generation 2024 Mullen FIVE EV is going to use a traditional lithium-ion battery pack, but the brand wants to use solid-state technology for the second generation.…

Continue Reading

Contact us: (310) 299-1717